Objective: We aim to assess which variables are associated with recruitment failure of RCTs, leading to an extension of the study period.. Design: Nationwide cohort study. Setting: A cohort of RCTs supported by the trial centre of the Dutch Consortium of Obstetrics and Gynaecology. Population: We included 83 RCTs that recruited patients between March 1 2003 and December 1 2023. Main outcome measures: Primary outcome was recruitment target not achieved within six months after the pre-planned recruitment period. Secondary outcomes were recruitment target not achieved within an extension period of at least twelve months and premature termination of the trial. Results: In total, 46 of 83 RCTs (55%) did not achieve their targeted recruitment within the pre-planned study period with a maximal extension period of 6 months. The most relevant indicators for recruitment failure in multivariable risk prediction modelling were presence of a no-treatment arm, a compensation fee of less than 200 euros per included patient, funding of less than 350.000 euros, while a preceding pilot study lowered this risk. Conclusions: We identified that the presence of a no-treatment arm, low funding and a low compensation fee per included patient were the most relevant risk factors for recruitment failure within the pre-planned period, while a preceding pilot study lowered this risk. Awareness of these indicators is important when designing future studies.
No takes yet. Share an insight, caveat, or question.
JFW et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: